Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adel Rafeh El Boueiz, M.D.

Concepts (231)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Adel El Boueiz's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Adel El Boueiz has written about over time.
Xanthine Dehydrogenase, 2 publications between 2008 and 2008, average publication date May 2008. p38 Mitogen-Activated Protein Kinases, 3 publications between 2008 and 2010, average publication date April 2009. Professional Practice, 1 publications between 2010 and 2010, average publication date November 2010. Bronchodilator Agents, 2 publications between 2016 and 2019, average publication date October 2017. Activin Receptors, Type I, 1 publications between 2019 and 2019, average publication date March 2019. Disease Progression, 13 publications between 2016 and 2022, average publication date October 2019. Forced Expiratory Volume, 6 publications between 2017 and 2021, average publication date November 2019. Bronchitis, Chronic, 2 publications between 2019 and 2021, average publication date April 2020. Spirometry, 5 publications between 2018 and 2021, average publication date May 2020. Pulmonary Disease, Chronic Obstructive, 19 publications between 2016 and 2024, average publication date May 2020. Pulmonary Emphysema, 6 publications between 2017 and 2024, average publication date May 2020. Smoking, 6 publications between 2017 and 2021, average publication date October 2020. Vital Capacity, 3 publications between 2019 and 2021, average publication date October 2020. Heterozygote, 3 publications between 2020 and 2022, average publication date January 2021. Bronchitis, 1 publications between 2021 and 2021, average publication date April 2021. Polyadenylation, 1 publications between 2021 and 2021, average publication date November 2021. alpha 1-Antitrypsin, 1 publications between 2022 and 2022, average publication date February 2022. Emphysema, 2 publications between 2022 and 2024, average publication date April 2023.

To see the data from this visualization as text, click here.
El Boueiz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (231)
Explore
_
Co-Authors (45)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.